68 related articles for article (PubMed ID: 10064053)
1. T cell-tumor cell: a fatal interaction?
Chappell DB; Restifo NP
Cancer Immunol Immunother; 1998 Oct; 47(2):65-71. PubMed ID: 9769114
[TBL] [Abstract][Full Text] [Related]
2. Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels.
Bruserud O; Ulvestad E
Cancer Immunol Immunother; 2000 Sep; 49(7):377-87. PubMed ID: 10999464
[TBL] [Abstract][Full Text] [Related]
3. Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC).
Ostrand-Rosenberg S; Sinha P; Chornoguz O; Ecker C
Cancer Immunol Immunother; 2012 Aug; 61(8):1319-25. PubMed ID: 22546994
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis in autoimmune diabetes: the fate of beta-cells in the cleft between life and death.
Sia C; Hänninen A
Rev Diabet Stud; 2006; 3(1):39-46. PubMed ID: 17491711
[TBL] [Abstract][Full Text] [Related]
5. uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma.
Malla RR; Gopinath S; Gondi CS; Alapati K; Dinh DH; Tsung AJ; Rao JS
J Neurooncol; 2012 Mar; 107(1):69-80. PubMed ID: 21964739
[TBL] [Abstract][Full Text] [Related]
6. Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.
Ivanov VN; Hei TK
Exp Cell Res; 2006 May; 312(8):1401-17. PubMed ID: 16487513
[TBL] [Abstract][Full Text] [Related]
7. The role of CD4 in regulating homeostasis of T helper cells.
König R; Shen X; Maroto R; Denning TL
Immunol Res; 2002; 25(2):115-30. PubMed ID: 11999166
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-treated baby hamster kidney cells.
Simizu S; Shibasaki F; Osada H
Jpn J Cancer Res; 2000 Jul; 91(7):706-14. PubMed ID: 10920278
[TBL] [Abstract][Full Text] [Related]
9. The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells.
Suzuki I; Fink PJ
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1707-12. PubMed ID: 10677522
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction.
Ju ST; Matsui K; Ozdemirli M
Int Rev Immunol; 1999; 18(5-6):485-513. PubMed ID: 10672498
[TBL] [Abstract][Full Text] [Related]
11. Cell death induced by the Fas/Fas ligand pathway and its role in pathology.
Waring P; Müllbacher A
Immunol Cell Biol; 1999 Aug; 77(4):312-7. PubMed ID: 10457197
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively.
Tóth R; Szegezdi E; Molnár G; Lord JM; Fésüs L; Szondy Z
Eur J Immunol; 1999 Feb; 29(2):383-93. PubMed ID: 10064053
[TBL] [Abstract][Full Text] [Related]
13. Retinoids induce Fas(CD95) ligand cell surface expression via RARgamma and nur77 in T cells.
Tóth B; Ludányi K; Kiss I; Reichert U; Michel S; Fésüs L; Szondy Z
Eur J Immunol; 2004 Mar; 34(3):827-836. PubMed ID: 14991612
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase ctheta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death.
Villalba M; Kasibhatla S; Genestier L; Mahboubi A; Green DR; Altman A
J Immunol; 1999 Dec; 163(11):5813-9. PubMed ID: 10570264
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells.
Tóth R; Szegezdi E; Reichert U; Bernardon JM; Michel S; Ancian P; Kis-Tóth K; Macsári Z; Fésüs L; Szondy Z
Eur J Immunol; 2001 May; 31(5):1382-91. PubMed ID: 11465095
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
